Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer-Reference-Cited by-同舟云学术

Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer

Published:2016-05-01 Issue:5 Volume:152 Page:533
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Karia Pritesh S.¹,Azzi Jamil R.²,Heher Eliot C.³,Hills Victoria M.¹,Schmults Chrysalyne D.¹

Affiliation:

1. Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

2. Division of Renal Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

3. Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston4Transplant Center, Massachusetts General Hospital, Harvard Medical School, Boston

Publisher

American Medical Association (AMA)

Subject

Dermatology

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Skin Cancer in the Immunocompromised Patient;Rook's Textbook of Dermatology;2024-03-19

2. Targeting accelerated pulmonary ageing to treat chronic obstructive pulmonary disease‐induced neuropathological comorbidities;British Journal of Pharmacology;2023-11-15

3. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention–Update 2023;European Journal of Cancer;2023-11

4. Post‐Transplant Malignancy and Lymphoproliferative Diseases;Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease;2023-09-08

5. Immune Checkpoint Inhibitors in Solid Organ Transplant Recipients With Advanced Skin Cancers—Emerging Strategies for Clinical Management;Transplantation;2023-06-20